Chlorpromazine versus atypical antipsychotic drugs for schizophrenia

Keyphrases

• Confidence Interval 100%
• Schizophrenia 100%
• Atypical Antipsychotics 100%
• Chlorpromazine 100%
• Randomized Controlled Trial 94%
• Risk Ratio 61%
• Olanzapine 22%
• Quetiapine 22%
• Extrapyramidal Symptoms 22%
• Risperidone 22%
• Adverse Effects 16%
• Quality of Life 16%
• Between-group 16%
• Mental States 16%
• Clinical Response 16%
• Brief Psychiatric Rating Scale 16%
• Antipsychotics 16%
• Second-generation Antipsychotics 16%
• People with Schizophrenia 11%
• China 5%
• Search Methods 5%
• Extracted Data 5%
• Selection Criteria 5%
• Literature Search 5%
• Dose-ranging 5%
• Limited Resources 5%
• High Dose 5%
• Chinese Population 5%
• Inclusion Criteria 5%
• Continuous Data 5%
• Economic Cost 5%
• Physical Health 5%
• Cochrane 5%
• Cochrane Review 5%
• Risk of Bias 5%
• Adverse Events 5%
• Review Authors 5%
• Dichotomous Data 5%
• Phenothiazine 5%
• Typical Antipsychotics 5%
• GRADE Approach 5%
• General Quality of Life 5%
• Short-term Study 5%
• Schizoaffective Disorder 5%
• Schizophreniform Disorder 5%
• Delusional Disorder 5%

Pharmacology, Toxicology and Pharmaceutical Science

• Randomized Controlled Trial 100%
• Atypical Antipsychotics 100%
• Chlorpromazine 100%
• Adverse Event 23%
• Risperidone 23%
• Antipsychotic 23%
• Olanzapine 23%
• Quetiapine 23%
• Typical Antipsychotic 23%
• Phenothiazine 5%
• Group Trial 5%
• Extrapyramidal Symptoms 5%
• Schizophreniform Disorder 5%
• Schizoaffective Psychosis 5%
• Delusional Disorder 5%